2025. Informative Censoring in CDK4/6 Inhibitor Adjuvant Therapy for Early Breast Cancer: A Sensitivity Analysis of Invasive Disease-Free Survival in the monarchE Trial. Epidemiology, Biostatistics, and Public Health. (Sep. 2025). DOI:https://doi.org/10.54103/2282-0930/29562.